Ray Co

Ray Co Equity Ratio

The Equity Ratio of Ray Co (228670.KQ) as of Nov 18, 2026 is 39.79 %. In the previous year, Equity Ratio was 35.93 % — a change of 10.75% (higher).

Equity Ratio

39.79 %

YoY

10.75%

Last updated:

Equity Ratio of Ray Co is 2025 39.79 % . Equity Ratio of Ray Co was 2024 35.93 % . It decreases by 10.75% higher compared to the previous year.

The Ray Co Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
63.66 KRW
Jan 1, 2019
75.05 KRW
Jan 1, 2020
73.19 KRW
Jan 1, 2021
56.80 KRW
Jan 1, 2022
52.34 KRW
Jan 1, 2023
49.04 KRW
Jan 1, 2024
35.93 KRW
Jan 1, 2025
39.79 KRW
The Ray Co Equity Ratio history
YEAREquity RatioYoY
39.79 %+10.75%
35.93 %-26.73%
49.04 %-6.32%
52.34 %-7.85%
56.80 %-22.39%
73.19 %-2.48%
75.05 %+17.89%
63.66 %+11.84%
56.93 %+3.34%
55.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Equity Ratio of Ray Co is 39.79 % in 2025.

Equity Ratio of Ray Co changed from 35.93 % to 39.79 %, representing a 10.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Ray Co since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Ray Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ray Co

All Key Metrics — Ray Co